Chien-liang Lin, PhD

C. Glenn Lin completed his doctorate in molecular biology and biochemistry at the Johns Hopkins University in 1995. He performed postdoctoral research in the Department of Neurology at the Johns Hopkins University. Dr. Lin joined the Department of Neuroscience at the Ohio State University in 1999, where he directed his research to molecular mechanisms underlying neurodegenerative diseases, including Alzheimer’s disease, amyotrophic lateral sclerosis (ALS) and epilepsy. His recent research focuses on the role of glutamate transporter EAAT2 in the regulation of synaptic plasticity and function and in the pathogenesis of neurodegenerative diseases. He has published numerous papers in major journals and holds four patents.